Children at risk of developing asthma saw a reduction or elimination of their symptoms when treated early with ALK’s Grazax asthma drug, according to results from a five-year clinical trial published in The Journal of Allergy and Clinical Immunology.
With the number of blood donations falling more than 60,000 short of demand during the last quarter, the American Red Cross is reminding all eligible donors that their participation may be a matter of life or death.
The U.S. Food and Drug Administration said it is taking steps to promote wider access to lower-cost alternatives to prescription medication and facilitating efforts to bring more generic medications to the market.dd Teaser here
In an effort to make precision medicine more accessible, Rennova Health Inc. subsidiary Advanced Molecular Services Group (AMS Group) has partnered with Certainty Health to develop smartphone tools that will help incorporate patients’ genetic backgrounds into psychiatric treatment.
PatientPoint, a patient education and engagement solutions company, recently generated $140 million in investment from Searchlight Capital Partners and Silver Point Capital that will go towards expansion.
Grants worth $2 million will be disbursed for research into the best way to minimize the side effects caused by groundbreaking immunotherapy drugs under through a joint venture by the American Cancer Society and the Melanoma Research Alliance.
U.S. News & World Report recently ranked St. Jude Children’s Research Hospital in Memphis the top pediatric cancer hospital in the country, with St. Jude earning a perfect score and topping more than 5,000 medical centers throughout the country.
Grady Health System’s Marcus Stroke and Neuroscience Center in Atlanta recently opened a new outpatient center that will focus on multidisciplinary care and is part of an expansion of the system’s research capabilities.
Positive results from a Phase 3 clinical trial recently prompted the European Commission to approve Besponsa, Pfizer Inc.’s new immunotherapy treatment for patients suffering from B-cell precursor acute lymphoblastic leukemia, the pharmaceutical said in a release.
The results of two studies on the fertility drug Rekovelle showing the drug’s efficacy and safety during in vitro fertilization were presented at the European Society of Human Reproduction and Embryology’s 33rd annual meeting in Geneva, Switzerland.
In a recent opinion column in Forbes, Grace-Marie Turner, founder and president of the Galen Institute, a nonprofit public policy research organization, said biosimilar prescription pharmaceuticals can provide an avenue to keeping drug prices low.